Foreign Regulatory Systems Can Be Strengthened By Receiving U.S. FDA Inspection Data, IOM Says
This article was originally published in PharmAsia News
Executive Summary
Institute of Medicine report recommends how U.S. FDA, industry and other stakeholders can strengthen food and drug regulatory systems abroad. It calls for FDA to provide incentives for foreign regulators to meet U.S. standards and facilitate training and for the government to help hold importers liable.